Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
Authors not listed
Brigham and Women's Hospital · 2021
Abstract
The objective of this study is to establish a near-real-time prospective monitoring program in Medicare, Optum and MarketScan Research data to evaluate the benefit of new cardiovascular disease (CVD) drugs for older adults with frailty. Prospective monitoring program seeks to find early effectiveness and safety signals of new drugs by updating the analysis at regular intervals as new Medicare data become available. This study specifically aims to emulate a prospective surveillance of the effectiveness and safety of Angiotensin Receptor Neprilysin Inhibitor(ARNI) vs. a comparator, Angiotensin II Receptor Blockers (ARBs), in older adults with Heart Failure with Reduced Ejection Fraction (HFrEF) and different frailty status. This program will be enhanced by incorporating a novel claims-based frailty index, which has been shown useful in assessing how the benefits and harms of drug therapy vary by frailty.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Anonymous. (2021). Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty. <em>Brigham and Women's Hospital</em>. https://clinicaltrials.gov/study/NCT04743063
Vancouver
Anonymous. Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty. Brigham and Women's Hospital. 2021.
BibTeX
@misc{anon2021Prospe,
title = {Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty},
author = {Anonymous},
journal = {Brigham and Women's Hospital},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brigham and Women's Hospital 2021
Open access · US-GOV
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
The Journals of Gerontology Series A 2023
Open access · OA
Novel Potential Targets for Function-Promoting Therapies: Orphan Nuclear Receptors, Anti-inflammatory Drugs, Troponin Activators, Mas Receptor Agonists, and Urolithin A
University of Florida 2015
Open access · US-GOV
A New Adaptive Physical Activity Technology in Older Adults (Jintronix)
Indonesian Journal of Chemical Studies 2024
Open access · CC-BY
Novel Natural Deep Eutectic Solvent (NaDES) Yellow Choline Chloride and Molecular Docking Soybean Extract (Glycine max) as Diabetes Drugs Candidate
Journal of the American College of Cardiology 2010
Preprint · OA